Ivy Altomare

VP, Clinical Research Paradigm Health

Ivy Altomare, M.D., is a medical oncologist and the Vice President of Clinical Research at Paradigm Health, where she serves as the clinical lead for Paradigm’s integrated and tech-enabled prospective evidence platform. She works closely with pharmaceutical sponsors and NCI-funded consortia to evaluate evidence needs and advance pragmatic trials enhanced by Paradigm Health’s technology. She also leads the team of clinicians supporting trial operations and collaborates with investigators at academic medical centers and community oncology practices using Paradigm’s interoperable digital tools to accelerate clinical trial efficiency.  She is an established clinical researcher, an award-winning educator, has authored over 100 peer- reviewed publications, and has been an invited speaker at events sponsored by the Clinical Trials Transformation Initiative (CTTI), Duke Margolis Institute for Health Policy, NCCN, ASCO, ASH, the Cancer Business Exchange, OncLive, and OncoDaily.

Seminars

Wednesday 28th October 2026
EHR-Embedded Technology to Accelerate Prospective Evidence Generation
2:30 pm
  • Embedding AI-powered research workflows directly within  the EHR to identify eligible patients and streamline study  execution.
  • Scaling prospective evidence generation through an  integrated platform that connects technology, providers, and  research operations.
  • Reducing operational burden while expanding access to  research opportunities across community practices, academic  centers and health systems
  • Case study: Accelerating enrollment and prospective  evidence generation in a multicenter cancer clinical trial
Ivy